What is the recommended treatment for cat scratch disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The recommended treatment for cat scratch disease is azithromycin, with a dose of 500 mg on day 1 followed by 250 mg daily for 4 additional days for patients weighing ≥45.5 kg, and 10 mg/kg on day 1 followed by 5 mg/kg daily for 4 additional days for patients weighing <45.5 kg, as supported by the Infectious Diseases Society of America guidelines 1.

Key Considerations

  • The disease is caused by the bacterium Bartonella henselae, which is transmitted through cat scratches or bites, particularly from kittens.
  • Mild cases of cat scratch disease often resolve on their own within 2-4 months without specific treatment, but antibiotic therapy is recommended for more severe or persistent cases.
  • Azithromycin is the first-line treatment, with alternative antibiotics including trimethoprim-sulfamethoxazole, ciprofloxacin, or rifampin for 7-14 days.
  • Lymph node aspiration may be performed if nodes are particularly painful or suppurative to provide symptomatic relief, and warm compresses can help reduce pain and inflammation.

Treatment Details

  • The dosing protocol for azithromycin is as follows:
    • Patients >45 kg: 500 mg on day 1 followed by 250 mg for 4 additional days.
    • Patients <45 kg: 10 mg/kg on day 1 and 5 mg/kg for 4 more days.
  • It is essential to avoid squeezing or incising lymph nodes, as this may delay healing.

Evidence Support

  • The recommended treatment is based on the Infectious Diseases Society of America guidelines, which provide strong, moderate evidence for the use of azithromycin in cat scratch disease 1.

From the Research

Treatment Overview

  • The recommended treatment for cat scratch disease varies depending on the severity of the infection and the patient's immune status.
  • According to 2, the majority of cases of cat-scratch disease occurring in normal hosts do not require anti-infective therapy for resolution of infection.
  • However, severe or persistent cases may require antibiotic therapy, with options including azithromycin, rifampin, ciprofloxacin, gentamicin, trimethoprim and sulfamethoxazole, clarithromycin, and erythromycin 2, 3.

Antibiotic Treatment

  • Azithromycin has been shown to be effective in treating cat scratch disease, with one study demonstrating more rapid diminution in size of infected lymph nodes 2.
  • A combination of azithromycin and rifampicin may be used in cases of disseminated disease or in immunosuppressed patients 4.
  • Other antibiotics, such as doxycycline and erythromycin, may also be effective in treating cat scratch disease 3.

Special Considerations

  • Immunocompromised individuals, such as those with AIDS or undergoing immunosuppressive therapy, may require more aggressive treatment and closer monitoring 3, 4.
  • In cases of disseminated disease or severe complications, such as encephalopathy or endocarditis, hospitalization and intravenous antibiotic therapy may be necessary 3, 4.
  • A comprehensive evaluation, including a detailed medical history, physical examination, and histological and microbiological assessments, is crucial in diagnosing and treating cat scratch disease, especially in immunosuppressed patients 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of cat-scratch disease.

Current opinion in pediatrics, 2001

Research

Cat-scratch disease and related clinical syndromes.

American family physician, 1997

Research

Disseminated cat-scratch disease during abatacept therapy for rheumatoid arthritis in an older patient: A case report and review of the literature.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.